Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Taro Kamimura"'
Autor:
Hideaki Oka, Yuko Sakurai, Taro Kamimura, Taichi Murakami, Takeshi Sato, Takanari Kitazono, Toshiaki Nakano
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background Although 70% of Japanese individuals wish to die at home, the in-hospital death rate in Japan is 71%. The in-hospital death rate is more than 80% in dialysis patients, most of whom are hemodialysis patients. Few reports exist on t
Externí odkaz:
https://doaj.org/article/f77440344446464fa6e539b7bcd77706
Autor:
Kento Fukumitsu, Hideaki Oka, Takaki Iwamoto, Mika Kondo, Yutaro Hirashima, Taro Kamimura, Toshiaki Nakano, Takanari Kitazono
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Identification of the pathogenesis of peritoneal dialysis (PD)-related peritonitis is important. However, identification of endogenous peritonitis, especially hematogenous infection, is difficult, and there are few reports of endo
Externí odkaz:
https://doaj.org/article/9db8bb205843478586ac397632374a92
Autor:
Seishi Aihara, Shunsuke Yamada, Hideaki Oka, Taro Kamimura, Toshiaki Nakano, Kazuhiko Tsuruya, Atsumi Harada
Publikováno v:
Renal Failure, Vol 41, Iss 1, Pp 88-97 (2019)
Background: Eldecalcitol (ELD) is an active vitamin D3 analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia. However, few reports have focused on acute kidney injury (AKI
Externí odkaz:
https://doaj.org/article/f7446717e6f74bc5b5bd5ca2c2aa5a02
Autor:
Seishi Aihara, Shunsuke Yamada, Mika Kondo, Hideaki Oka, Taro Kamimura, Atsumi Harada, Toshiaki Nakano, Kazuhiko Tsuruya, Takanari Kitazono
Publikováno v:
Case Reports in Nephrology, Vol 2019 (2019)
An 82-year-old man treated with phenytoin for the prevention of symptomatic epilepsy was hospitalized to treat consciousness disturbance, seizure, and hypocalcemia (serum calcium: 4.6 mg/dL). Serum 25-hydroxyvitamin D level was very low (5.4 ng/mL),
Externí odkaz:
https://doaj.org/article/aa986a3c10d64dcbac9f7e16a0a72dbd
Autor:
Rie Kato, Mika Kondo, Saki Iwamoto, Takaki Iwamoto, Yutaro Hirashima, Hideaki Oka, Taro Kamimura
Publikováno v:
Nihon Naika Gakkai Zasshi. 111:594-598
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86f7c0a76da819934aa1d8faf9409ddd
https://doi.org/10.2169/naika.111.594
https://doi.org/10.2169/naika.111.594
Publikováno v:
Nihon Naika Gakkai Zasshi. 110:2601-2606
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e49b3704ab8f932855dd07a2cbc431f8
https://doi.org/10.2169/naika.110.2601
https://doi.org/10.2169/naika.110.2601
Autor:
Yoshito Homma, Hideaki Oka, Hideki Makino, Mizuki Sekimoto, Yoichi Kondo, Takeshi Matsuda, Mika Kondo, Saki Iwamoto, Norio Sato, Taro Kamimura, Shota Ando, Yuko Sakurai, Yoshiko Onji, Kotaro Kajiwara, Takaki Iwamoto
Publikováno v:
Nihon Toseki Igakkai Zasshi. 54:583-589
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ccd90e4cb2b6fae84277e5e693fba56
https://doi.org/10.4009/jsdt.54.583
https://doi.org/10.4009/jsdt.54.583
Autor:
Hideaki Oka, Yoshito Homma, Yuki Nishino, Koichiro Suemori, Norio Sato, Yuko Sakurai, Mizuki Sekimoto, Shota Ando, Saki Iwamoto, Takaki Iwamoto, Mika Kondo, Taro Kamimura, Toshiaki Nakano, Takanari Kitazono
Publikováno v:
Internal medicine (Tokyo, Japan). 61(12)
A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f02995dd271af1f19c2d179df1275280
https://pubmed.ncbi.nlm.nih.gov/35400699
https://pubmed.ncbi.nlm.nih.gov/35400699
Autor:
Shunsuke Yamada, Kazuhiko Tsuruya, Toshiaki Nakano, Taro Kamimura, Hideaki Oka, Atsumi Harada, Seishi Aihara
Publikováno v:
Renal Failure, Vol 41, Iss 1, Pp 88-97 (2019)
Renal Failure
Renal Failure
Background: Eldecalcitol (ELD) is an active vitamin D3 analog that is widely used in Japan for the treatment of osteoporosis. The most common adverse drug reaction of ELD is hypercalcemia. However, few reports have focused on acute kidney injury (AKI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b80edf6c90c04a903cf1c6ce079b506c
https://doi.org/10.1080/0886022x.2019.1578667
https://doi.org/10.1080/0886022x.2019.1578667
Autor:
Toshiaki Nakano, Taro Kamimura, Masahide Hyodo, Hideaki Oka, Atsumi Harada, Seishi Aihara, Kazuhiko Tsuruya, Nagaaki Terakado, Takanari Kitazono, Shunsuke Yamada
Publikováno v:
Therapeutic Apheresis and Dialysis. 23:187-194
Some peritoneal dialysis (PD)-related peritonitis cases are thought to be caused by the pathogens in the oral cavity; however, the relationship between peritonitis and oral hygiene habits is unclear. In this study, we retrospectively examined the rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df7b2506fdef036375f8c1b358e61c05
https://doi.org/10.1111/1744-9987.12757
https://doi.org/10.1111/1744-9987.12757